# Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis

> **NCT06582940** · PHASE2 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 168 (estimated)

## Conditions studied

- MRI-guided Adaptive Radiotherapy
- Non-small Cell Lung Cancer
- Brain Metastasis

## Interventions

- **RADIATION:** MRI-guided adaptive SRT
- **RADIATION:** Conventional SRT

## Key facts

- **NCT ID:** NCT06582940
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06582940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06582940, "Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06582940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*